Clinical Research Directory
Browse clinical research sites, groups, and studies.
Using Novel Imaging to More Safely Treat Neuroendocrine Tumors
Sponsor: University of Wisconsin, Madison
Summary
The goal of this research is to determine if DetectnetTM PET/CT can be used to make Lutathera therapy safer for patients with neuroendocrine cancer. Participants will: * Complete two phases involving 6 visits * Undergo additional research PET/CT, and possibly SPECT/CT scans
Official title: Dosimetry-Guided 177Lu-DOTATATE Treatment Planning Using 64Cu-DOTATATE as a Surrogate
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2025-03-07
Completion Date
2026-06
Last Updated
2026-03-19
Healthy Volunteers
No
Interventions
Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
SPECT/CT will be performed after first cycle of Lutathera® treatment
Photon Emission Tomography / CT (PET/CT)
PET/CT will be performed after 64Cu-DOTATATE and Lutathera® treatment
64Cu-Dotatate
Standard of care administration of radioactive drug for PET/CT
177Lu-Dotatate
Standard of care administration of radioactive drug for PET/CT and SPECT/CT
Locations (1)
University of Wisconsin - Madison
Madison, Wisconsin, United States